Abstract
Introduction
Parathyroid hormone-related protein (PTHrP) is widely expressed in normal human tissues where it plays a role in cell proliferation and differentiation in an autocrine or paracrine fashion (1) (2) (3) . PTHrP has also been reported to be the main factor associated with humoral hypercalcemia of malignancy (HHM) (4, 5) . There are several reports showing hypercalcemia associated with high plasma PTHrP levels in patients with benign tumors (6) (7) (8) (9) (10) (11) (12) . However, this is the first report, to our knowledge, of a patient with a normal serum calcium level who had a benign tumor producing PTHrP.
Case Report
A 64-year-old woman was referred to our department for evaluation of neck tumors. She (17) . In the present case, the thyroid tumors might have had the potential to undergo malignant transformation in the future.
Discussion

In 1979, Stewart et al first used the term "humoral hypercalcemia of malignancy (HHM)" to refer to the association between malignant tumors and hypercalcemia (15). Subsequently, a peptide was purified from tumors associated with HHM. In 1987, Moseley et al referred this cancer-derived protein as PTHrP, which was considered to be the primary factor in HHM (4). On the other hand, Knecht et al defined a syndrome called humoral hypercalcemia of benignancy (HHB), in which PTHrP was secreted from benign tumors (6, 16). There have been some case reports of HHB associated with an ovarian dermoid cyst, massive mammary hyperplasia, pheochromocytoma, and uterine leiomyoma (6-12). The present patient was first revealed to have neck tumors by ultrasonography. Because of elevation of the plasma level of "PTHrP-like protein", the possibility of malignant disease was suggested and extensive work-up was performed, but no solid tumors or hematologic malignancy was detected. We reached a conclusion that the "PTHrP-like protein" was produced by her thyroid follicular adenomas, which was confirmed by its disappearance after removal of the tumors and by immunohistochemical staining of the resected specimens for anti-PTHrP antibody. Nakashima et al reported on the distribution of PTHrP in human thyroid tissues (17) after comparing 107 human thyroid tumors with 51 normal thyroid tissue samples, examining PTHrP expression by staining with a monoclonal anti-PTHrP antibody (38-64), and measuring PTHrP mRNA levels by in situ hybridization and reverse transcriptase polymerase chain reaction (RT-PCR). Both immunostaining and in situ hybridiza
The normal physiologic role of PTHrP is not thoroughly understood, but it is considered to be involved in normal calcium homeostasis (18) , regulation of smooth muscle (19) , and regulation of tissue and organ development, differentiation, and proliferation (1-3, 20, 21 , , , and (27) . In the patients with HHB, the serum 1,25-dihydroxy vitamin D3 concentration was reported to be low or normal (6, 10, 12 
